AKBA
Akebia Therapeutics, Inc.
-0.03 (-2.77%)0.89USD3.7M成交股數247M市值–本益比(近四季)1.1股價營收比-21.4%營收年增(近四季)2026-11-09下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 1 · 62K · 1 |
| 其中 10b5-1 計畫賣出 | 1 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 62K |
| 近 180 天 淨額 | −62K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | 08-10 | Butler John P. | CEO and President | M 選擇權執行 | 350K | 0.63 | 221K | 3.7M | SEC |
| 2026-06-29 | 07-01 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | S 公開市場賣出(10b5-1) | 56.0K | 1.11 | 62K | 617K | SEC |
| 2026-06-17 | 06-22 | FRIESON RON | Director | A 獲配股票 | 35.7K | – | – | 165K | SEC |
| 2026-06-17 | 06-22 | Smith Cynthia | Director | A 獲配股票 | 35.7K | – | – | 197K | SEC |
| 2026-06-17 | 06-22 | ZUMWALT LEANNE M | Director | A 獲配股票 | 35.7K | – | – | 145K | SEC |
| 2026-06-17 | 06-22 | Wolf Myles | Director | A 獲配股票 | 35.7K | – | – | 169K | SEC |
| 2026-06-17 | 06-22 | ROGERS MICHAEL W | Director | A 獲配股票 | 35.7K | – | – | 197K | SEC |
| 2026-06-17 | 06-22 | ADAMS ADRIAN | Director | A 獲配股票 | 35.7K | – | – | 236K | SEC |
| 2026-03-04 | 03-05 | Butler John P. | CEO and President | P 公開市場買進 | 69.3K | 1.25 | 87K | 3.4M | SEC |
| 2026-02-02 | 02-04 | Butler John P. | CEO and President | A 獲配股票 | 175K | 1.41 | 247K | 3.4M | SEC |
| 2026-02-02 | 02-04 | Rucci Carolyn M. | SVP, Chief Legal Officer | S 公開市場賣出(10b5-1) | 25.4K | 1.39 | 35K | 616K | SEC |
| 2026-02-02 | 02-04 | Rucci Carolyn M. | SVP, Chief Legal Officer | S 公開市場賣出(10b5-1) | 27.5K | 1.39 | 38K | 588K | SEC |
| 2026-02-02 | 02-04 | Butler John P. | CEO and President | S 公開市場賣出(10b5-1) | 115K | 1.39 | 160K | 3.2M | SEC |
| 2026-02-02 | 02-04 | Butler John P. | CEO and President | S 公開市場賣出(10b5-1) | 83.7K | 1.39 | 116K | 3.3M | SEC |
| 2026-02-02 | 02-04 | Butler John P. | CEO and President | S 公開市場賣出(10b5-1) | 46.7K | 1.39 | 65K | 3.4M | SEC |
| 2026-02-02 | 02-04 | Burke Steven Keith | SVP, Chief Medical Officer | S 公開市場賣出(10b5-1) | 21.6K | 1.39 | 30K | 995K | SEC |
| 2026-02-02 | 02-04 | Malabre Richard C | SVP, Chief Accounting Officer | S 公開市場賣出(10b5-1) | 13.4K | 1.39 | 19K | 299K | SEC |
| 2026-02-02 | 02-04 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | S 公開市場賣出(10b5-1) | 35.0K | 1.39 | 49K | 673K | SEC |
| 2026-02-02 | 02-04 | Grund Nicholas | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 31.2K | 1.39 | 43K | 562K | SEC |
| 2026-02-02 | 02-04 | Grund Nicholas | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 53.6K | 1.39 | 74K | 593K | SEC |
| 2026-02-02 | 02-04 | Malabre Richard C | SVP, Chief Accounting Officer | S 公開市場賣出(10b5-1) | 36.1K | 1.39 | 50K | 313K | SEC |
| 2026-02-02 | 02-04 | Rucci Carolyn M. | SVP, Chief Legal Officer | S 公開市場賣出(10b5-1) | 16.8K | 1.39 | 23K | 641K | SEC |
| 2026-02-02 | 02-04 | Butler John P. | CEO and President | S 公開市場賣出(10b5-1) | 96.1K | 1.39 | 134K | 3.3M | SEC |
| 2026-02-02 | 02-04 | Burke Steven Keith | SVP, Chief Medical Officer | S 公開市場賣出(10b5-1) | 20.7K | 1.39 | 29K | 948K | SEC |
| 2026-02-02 | 02-04 | Burke Steven Keith | SVP, Chief Medical Officer | S 公開市場賣出(10b5-1) | 25.4K | 1.39 | 35K | 969K | SEC |
| 2026-01-30 | 02-03 | Malabre Richard C | SVP, Chief Accounting Officer | A 獲配股票 | 79.0K | – | – | 349K | SEC |
| 2026-01-30 | 02-03 | Grund Nicholas | Chief Commercial Officer | A 獲配股票 | 204K | – | – | 647K | SEC |
| 2026-01-30 | 02-03 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | A 獲配股票 | 204K | – | – | 708K | SEC |
| 2026-01-30 | 02-03 | Burke Steven Keith | SVP, Chief Medical Officer | A 獲配股票 | 204K | – | – | 1.0M | SEC |
| 2026-01-30 | 02-03 | Rucci Carolyn M. | SVP, Chief Legal Officer | A 獲配股票 | 190K | – | – | 658K | SEC |
| 2026-01-30 | 02-03 | Butler John P. | CEO and President | A 獲配股票 | 743K | – | – | 3.5M | SEC |
| 2025-06-30 | 07-01 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | S 公開市場賣出(10b5-1) | 41.3K | 3.67 | 152K | 504K | SEC |
| 2025-06-10 | 06-11 | ZUMWALT LEANNE M | Director | A 獲配股票 | 35.7K | – | – | 109K | SEC |
| 2025-06-10 | 06-11 | ADAMS ADRIAN | Director | A 獲配股票 | 35.7K | – | – | 201K | SEC |
| 2025-06-10 | 06-11 | ROGERS MICHAEL W | Director | A 獲配股票 | 35.7K | – | – | 162K | SEC |
| 2025-06-10 | 06-11 | Smith Cynthia | Director | A 獲配股票 | 35.7K | – | – | 161K | SEC |
| 2025-06-10 | 06-11 | Wolf Myles | Director | A 獲配股票 | 35.7K | – | – | 133K | SEC |
| 2025-06-10 | 06-11 | GILMAN STEVEN C | Director | A 獲配股票 | 35.7K | – | – | 153K | SEC |
| 2025-06-10 | 06-11 | FRIESON RON | Director | A 獲配股票 | 35.7K | – | – | 130K | SEC |
| 2025-06-09 | 06-11 | Malabre Richard C | SVP, Chief Accounting Officer | M 選擇權執行 | 15.0K | 1.68 | 25K | 282K | SEC |
| 2025-06-09 | 06-11 | Malabre Richard C | SVP, Chief Accounting Officer | S 公開市場賣出(10b5-1) | 15.0K | 4.01 | 60K | 267K | SEC |
| 2025-06-04 | 06-05 | Malabre Richard C | SVP, Chief Accounting Officer | S 公開市場賣出(10b5-1) | 13.3K | 3.53 | 47K | 267K | SEC |
| 2025-03-03 | 03-04 | Butler John P. | CEO and President | S 公開市場賣出(10b5-1) | 46.4K | 1.83 | 85K | 2.6M | SEC |
| 2025-03-03 | 03-04 | Burke Steven Keith | SVP, Chief Medical Officer | S 公開市場賣出(10b5-1) | 7.1K | 1.83 | 13K | 809K | SEC |
| 2025-02-03 | 02-04 | Butler John P. | CEO and President | S 公開市場賣出(10b5-1) | 46.3K | 2.10 | 97K | 2.7M | SEC |
| 2025-02-03 | 02-04 | Burke Steven Keith | SVP, Chief Medical Officer | S 公開市場賣出(10b5-1) | 27.2K | 2.10 | 57K | 816K | SEC |
| 2025-02-03 | 02-04 | Burke Steven Keith | SVP, Chief Medical Officer | S 公開市場賣出(10b5-1) | 23.3K | 2.10 | 49K | 843K | SEC |
| 2025-02-03 | 02-04 | Malabre Richard C | SVP, Chief Accounting Officer | S 公開市場賣出(10b5-1) | 30.2K | 2.10 | 63K | 280K | SEC |
| 2025-02-03 | 02-04 | Butler John P. | CEO and President | S 公開市場賣出(10b5-1) | 98.0K | 2.10 | 206K | 2.6M | SEC |
| 2025-02-03 | 02-04 | Grund Nicholas | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 55.6K | 2.10 | 117K | 443K | SEC |
| 2025-01-31 | 02-04 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | A 獲配股票 | 195K | – | – | 545K | SEC |
| 2025-01-31 | 02-04 | Malabre Richard C | SVP, Chief Accounting Officer | A 獲配股票 | 85.0K | – | – | 310K | SEC |
| 2025-01-31 | 02-04 | Butler John P. | CEO and President | A 獲配股票 | 701K | – | – | 2.7M | SEC |
| 2025-01-31 | 02-04 | Burke Steven Keith | SVP, Chief Medical Officer | A 獲配股票 | 195K | – | – | 867K | SEC |
| 2025-01-31 | 02-04 | Grund Nicholas | Chief Commercial Officer | A 獲配股票 | 195K | – | – | 498K | SEC |
| 2025-01-17 | 01-22 | FRIESON RON | Director | M 選擇權執行 | 20.1K | 0.45 | 9K | 93.8K | SEC |
| 2024-06-28 | 07-02 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | A 獲配股票 | 350K | – | – | 350K | SEC |
| 2024-06-06 | 06-10 | ROGERS MICHAEL W | Director | A 獲配股票 | 30.0K | – | – | 126K | SEC |
| 2024-06-06 | 06-10 | GILMAN STEVEN C | Director | A 獲配股票 | 30.0K | – | – | 117K | SEC |
| 2024-06-06 | 06-10 | FRIESON RON | Director | A 獲配股票 | 30.0K | – | – | 73.7K | SEC |
| 2024-06-06 | 06-10 | ZUMWALT LEANNE M | Director | A 獲配股票 | 30.0K | – | – | 73.7K | SEC |
| 2024-06-06 | 06-10 | Smith Cynthia | Director | A 獲配股票 | 30.0K | – | – | 125K | SEC |
| 2024-06-06 | 06-10 | ADAMS ADRIAN | Director | A 獲配股票 | 30.0K | – | – | 165K | SEC |
| 2024-06-06 | 06-10 | Wolf Myles | Director | A 獲配股票 | 30.0K | – | – | 97.7K | SEC |
| 2024-05-13 | 05-14 | Hadas Nicole R. | SVP, Chief Legal Officer | S 公開市場賣出(10b5-1) | 12.0K | 1.26 | 15K | 651K | SEC |
| 2024-05-13 | 05-14 | Dahan Michel | SVP, Chief Operating Officer | S 公開市場賣出(10b5-1) | 34.8K | 1.26 | 44K | 672K | SEC |
| 2024-02-29 | 03-01 | Butler John P. | CEO and President | S 公開市場賣出 | 46.6K | 1.58 | 74K | 2.0M | SEC |
| 2024-02-29 | 03-01 | Burke Steven Keith | SVP, Chief Medical Officer | S 公開市場賣出 | 7.2K | 1.58 | 11K | 696K | SEC |
| 2024-02-29 | 03-01 | Dahan Michel | SVP, Chief Operating Officer | S 公開市場賣出 | 8.7K | 1.58 | 14K | 707K | SEC |
| 2024-02-29 | 03-01 | Hadas Nicole R. | SVP, Chief Legal Officer | S 公開市場賣出 | 6.0K | 1.58 | 9K | 663K | SEC |
| 2024-02-27 | 02-29 | Burke Steven Keith | SVP, Chief Medical Officer | S 公開市場賣出(10b5-1) | 8.4K | 1.52 | 13K | 703K | SEC |
| 2024-02-27 | 02-29 | Butler John P. | CEO and President | S 公開市場賣出 | 37.7K | 1.52 | 57K | 2.1M | SEC |
| 2024-02-27 | 02-29 | Dahan Michel | SVP, Chief Operating Officer | S 公開市場賣出 | 10.7K | 1.52 | 16K | 716K | SEC |
| 2024-02-27 | 02-29 | Hadas Nicole R. | SVP, Chief Legal Officer | S 公開市場賣出(10b5-1) | 7.4K | 1.52 | 11K | 669K | SEC |
| 2024-02-01 | 02-02 | Butler John P. | CEO and President | S 公開市場賣出 | 46.5K | 1.68 | 78K | 2.1M | SEC |
| 2024-02-01 | 02-02 | Burke Steven Keith | SVP, Chief Medical Officer | S 公開市場賣出 | 24.3K | 1.68 | 41K | 711K | SEC |
| 2024-01-31 | 02-02 | Hadas Nicole R. | SVP, Chief Legal Officer | A 獲配股票 | 149K | – | – | 677K | SEC |
| 2024-01-31 | 02-02 | Butler John P. | CEO and President | A 獲配股票 | 604K | – | – | 2.2M | SEC |
| 2024-01-31 | 02-02 | Burke Steven Keith | SVP, Chief Medical Officer | A 獲配股票 | 202K | – | – | 736K | SEC |
| 2024-01-31 | 02-02 | Snow Ellen | SVP, CFO and Treasurer | A 獲配股票 | 149K | – | – | 519K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 20.0M | 22.8M | +1.3M (+7%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.3M | 12.9M | +155K (+1%) | 加碼 |
| AQR CAPITAL MANAGEMENT LLC | 9.2M | 10.4M | +7.4M (+411%) | 加碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 6.7M | 7.7M | +275K (+4%) | 加碼 |
| STATE STREET CORP | 5.4M | 6.1M | −6.2M (-54%) | 減碼 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 4.3M | 4.9M | +3.8M (+894%) | 加碼 |
| Nantahala Capital Management, LLC | 4.0M | 4.6M | +2.0M (+100%) | 加碼 |
| GOLDMAN SACHS GROUP INC | 3.7M | 4.2M | +86.3K (+2%) | 加碼 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 3.2M | 3.6M | +812K (+34%) | 加碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5M | 2.9M | +319K (+14%) | 加碼 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 2.4M | 2.8M | +1.1M (+88%) | 加碼 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.3M | 2.6M | +285K (+14%) | 加碼 |
| NORTHERN TRUST CORP | 2.2M | 2.5M | +215K (+11%) | 加碼 |
| VANGUARD FIDUCIARY TRUST CO | 1.9M | 2.2M | +129K (+7%) | 加碼 |
| FMR LLC | 1.9M | 2.1M | +536K (+40%) | 加碼 |
| Qube Research & Technologies Ltd | 1.8M | 2.0M | −616K (-26%) | 減碼 |
| 城堡 CITADEL ADVISORS LLC | 1.7M | 2.0M | +328K (+24%) | 加碼 |
| UBS Group AG | 1.4M | 1.6M | +605K (+79%) | 加碼 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 1.2M | 1.4M | −609K (-33%) | 減碼 |
| CITIGROUP INC | 1.1M | 1.3M | −1.7M (-61%) | 減碼 |
| Hennion & Walsh Asset Management, Inc. | 840K | 957K | +206K (+33%) | 加碼 |
| MORGAN STANLEY | 702K | 800K | +120K (+21%) | 加碼 |
| Invesco Ltd. | 695K | 792K | −25.2K (-4%) | 減碼 |
| MANGROVE PARTNERS IM, LLC | 667K | 760K | +291K (+77%) | 加碼 |
| AMERIPRISE FINANCIAL INC | 626K | 714K | +616K (+5926%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 170 -1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 37 / 38 / 67 / 33 |
| 機構合計持股 · 佔流通股 | 110M · 39.7% |
| 合計季末市值 | 120M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 23.0M |
|---|---|
| 與上期比 | +7.6% |
| 佔流通股數 | 8.30% |
| 日均成交量 | 9.8M |
| 回補天數 | 2.3 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 23.0M | +7.6% | 8.30% | 9.8M | 2.3 |
| 2026-08-14 | 21.4M | +11.4% | 7.71% | 6.0M | 3.5 |
| 2026-07-31 | 19.2M | +0.6% | 6.92% | 2.2M | 8.8 |
| 2026-07-15 | 19.1M | -0.5% | 6.88% | 4.5M | 4.2 |
| 2026-06-30 | 19.2M | -34.3% | 6.92% | 7.1M | 2.7 |
| 2026-06-15 | 29.2M | +6.5% | 10.54% | 5.2M | 5.6 |
| 2026-05-29 | 27.4M | +4.0% | 9.90% | 6.6M | 4.1 |
| 2026-05-15 | 26.4M | -4.5% | 9.52% | 4.6M | 5.7 |
| 2026-04-30 | 27.6M | +1.1% | 9.97% | 2.4M | 11.4 |
| 2026-04-15 | 27.3M | +4.0% | 9.86% | 2.0M | 13.5 |
| 2026-03-31 | 26.3M | -9.4% | 9.48% | 2.8M | 9.3 |
| 2026-03-13 | 29.0M | -2.4% | 10.46% | 2.8M | 10.3 |
| 2026-02-27 | 29.7M | -4.8% | 10.72% | 3.3M | 9.1 |
| 2026-02-13 | 31.2M | -15.5% | 11.26% | 4.4M | 7.1 |
| 2026-01-30 | 36.9M | -0.3% | 13.33% | 2.6M | 14.2 |
| 2026-01-15 | 37.0M | +2.7% | 13.36% | 3.3M | 11.1 |
| 2025-12-31 | 36.1M | +4.3% | 13.01% | 2.8M | 12.7 |
| 2025-12-15 | 34.6M | -3.7% | 12.48% | 3.4M | 10.3 |
| 2025-11-28 | 35.9M | +1.6% | 12.96% | 3.5M | 10.2 |
| 2025-11-14 | 35.3M | -0.5% | 12.75% | 6.5M | 5.5 |
| 2025-10-31 | 35.5M | +21.1% | 12.82% | 5.5M | 6.4 |
| 2025-10-15 | 29.3M | -0.3% | 10.58% | 2.7M | 10.9 |
| 2025-09-30 | 29.4M | +7.5% | 10.61% | 3.2M | 9.2 |
| 2025-09-15 | 27.4M | +1.0% | 9.87% | 3.9M | 7.1 |
| 2025-08-29 | 27.1M | +9.2% | 9.78% | 3.8M | 7.1 |
| 2025-08-15 | 24.8M | +1.1% | 8.95% | 4.5M | 5.5 |